At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Islet Transplantation in Type 1 Diabetic Kidney Allograft Recipients
In Brief
A Phase 2 clinical trial evaluating Purified Pancreatic Islets and Etanercept for Diabetes Mellitus, Type I. Completed, enrolled 7 participants across 1 site.
Detailed Summary
The purpose of the study is to learn if islet transplantation is an effective treatment for Type 1 diabetes in people who have had a kidney transplant. The primary objectives of the study are: \- To set up islet transplantation in patients who have had a kidney transplant and who are using an immunosuppressive regimen that works The Secondary objective of the study is: * To find out if successful islet transplantation leads to improved metabolic control and reduced renal complication from diabetes
Study Details
Timeline
Interventions
Islet after kidney transplant in patients with type I diabetes.
Given as induction for islet cell transplant